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The  HLA  D/DR  region  of the  human  major  histocompatibility  complex 
encodes a family of highly polymorphic, human "Ia-like" molecules that function 
as genetic restriction elements in a variety of immune phenomena (1, 2). Corre- 
lations  have  been  demonstrated  between disease  susceptibility and  particular 
HLA  D/DR  antigens  (1,  3,  4).  Recent  evidence  (5-7)  has  demonstrated  a 
considerable  heterogeneity  within  serologically  defined  clusters  of  HLA-DR 
antigens.  Individuals who are identical serologically can be shown to be distinct 
by the mixed lymphocyte reaction (MLR), thus defining unique HLA-D antigens. 
The view that HLA-DR is supertypic to the MLR-defined HLA-D specificities is 
supported by biochemical studies using two-dimensional polyacrylamide gels of 
immunoprecipitated Ia-like molecules from cell lines derived from phenotypically 
homozygous typing cell donors (homozygous cell lines, HCL). An analysis of the 
DR/3 chain patterns representative of different HLA-D clusters demonstrated a 
precise correlation  with  the  HLA-D phenotype of the homozygous typing cell 
(HTC) donor; i.e.,  HLA-D specificities reflected structural variations in the DR 
/3 chains (6, 7). This heterogeneity within a single DR haplotype is central to the 
concept that Ia structural diversity may account for those polymorphic determi- 
nants that are important  in Ia-controlled immune phenomena and HLA D/DR 
disease susceptibility. 
We have used (8) HLA-DR2, OKT4 + cytotoxic T  lymphocytes (CTL) specific 
for measles virus as the immunologically reactive cell population to investigate 
which HLA-DR structural epitopes can serve as genetic restriction elements for 
these HLA class II-restricted CTL clones. The HLA-DR2 serotype includes up 
to three separate sets of Ia-like molecules that are expressed on HLA-DR2 HTC 
lines (7). Two distinct/3 chains (DR/31 and DR/32) were present on most HLA- 
DR2 cell lines (7). DR/31 did not vary among eight HLA-DR2 HCL tested, while 
DR/32 was electrophoretically variable among the DR2 cells examined (7).  The 
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variability of DR/32 correlated with the MLR-defined HLA-D type of each HTC 
line tested (7). We report here that the molecules which are apparently recog- 
nized by T  cells in the MLR (DR/32) may also serve as the restriction element in 
the  Ia-restricted immune  response of OKT ÷,  HLA class  II-restricted measles, 
virus-specific CTL clones derived from a patient with multiple sclerosis (MS). 
Materials and Methods 
Homozygous Lymphoblastoid Cell Lines.  Cell lines CMcG, PAL, and SHI represent the 
common DR2-associated, HLA-Dw2 specificity; lines BGE, WJR, AZH, and WT18 were 
derived from HTC representing other non-Dw2 HLA-D specificities as described (7). 
Monoclonal  Anti-Ia  Antibodies.  Monoclonai  murine  antibodies  P4.1  and  S1.19  are 
specific for determinants on DR (IE-like)  molecules, as described (5).  Neither antibody 
reacts with non-DR, Ia-like molecules on these cells, such as the DQ (DS/DC) molecules. 
Both P4.1 and S 1.19 react with framework determinants on DR molecules independent 
of haplotype; identical gel patterns were obtained with both antibodies (7). 
Radiolabeling,  Immunoprecipitation,  and  Two-dimensional  Gel  Electrophoresis.  Lac- 
toperoxidase-catalyzed iodinations were performed as described previously (6, 7). Immu- 
noprecipitation using antibodies P4.1 and S. 19 followed by Cowan 1 strain Staphylococcus 
aureus (SaCI) (Bethesda Research Laboratories, Gaithersburg, MD). This was followed by 
electrophoresis using  nonequilibrium  pH,  polyacrylamide tube  gels  with  pH  3.5-10 
ampholines in the first dimension and sodium dodecyl sulfate-10% polyacrylamide slab 
gels with a discontinuous pH buffer system in the second dimension (7). Gels were dried 
and autoradiographed at -70°C with Kodak XR film and a Rarex intensifying screen. 
T  Cell Clones.  The measles virus-specific CTL clones CL34 and CL14 have been 
described previously and shown to lyse measles virus-infected B cell lines in association 
with  HLA-DR2  and  HLA-DR4,  respectively (8).  Clone  E4-4  has  been  shown  (8)  to 
proliferate specifically to measles virus in association with HLA-DR2 and to have a cell 
surface phenotype that was OKT3  ÷, OKT4  ÷, OKT8-. 
Cytotoxic Assay.  Clones were incubated at a ratio of 10:1 with a panel of ~Cr-labeled, 
measles  virus-infected lymphoblastoid  cell  lines.  B  cell  lines  were  infected with  the 
Edmonston strain of measles virus at a multiplicity of infection of 1.0 and then incubated 
for 3 d. CTL assays were performed as described previously (8). Percent specific lysis was 
calculated as described previously (9). Values are expressed as means of triplicate cultures. 
Uninfected B cell lines gave <1%  specific iysis when incubated with  the CTL clones. 
Spontaneous release of infected and uninfected B cell lines was  10-15%. CTL were also 
derived from bulk cultures by a primary, in vitro 7-d measles virus stimulation of M 15 
peripheral blood iymphocytes, (PBL) as described previously (8). 
Results 
Nine  Epstein-Barr virus-transformed  lymphoblastoid cell lines were  used  in 
this  study  (Table I).  Seven homozygous cell lines  (HCL) have been described 
previously  (7)  and  are  known  to  be  homozygous  for  one  of the  HLA-DR2- 
associated D  locus antigens Dw2, Dwl2,  LD "tb24", LD "AZH", or LD "WJR". 
One cell line (E3B) was derived from a  donor who is HLA-DR2,4 and is HLA- 
D  typed as tb24  (Dr.  David  Eckels,  personal  communication). The  M15B cell 
line, which is autologous to the measles virus-specific CTL clones used in this 
study, is HLA-DR2,4 and has an HLA-DR2-associated Dw2 type. Effector cells 
consisted of T  cell clones CL34, CL14, and E4-4. 
All  nine  lymphoblastoid cell  lines infected with  measles virus were lysed by 
CTL generated in bulk culture (Table I). Clone CL34 (DR2-restricted),  CL14 
(DR4-restricted),  and  E4-4  (DR2-restricted)  lysed  the  autologous  infected cell 
line M 15B (DR2,4). However, clones CL34 and E4-4 could only lyse those HLA- JACOBSON ET AL.  BRIEF  DEFINITIVE REPORT  265 
TABLE  I 
Lysis of Measles Virus-infected  B Cell Lines by CTL Clones 
Percent specific lysis* 
Measles virus-infected 
lymphoblastoid cell  HLA-DR  HLA-DR2 D type  T  cell clones  M 15 PBL 
line  CL34  E4-4  CLI4  anti-MV 
1  M15B  2,4  Dw2  55.3  31.9  61.6  41.8 
2  E3B  2,4  "tb24"  -2.5  3.5  61.5  19.4 
3  W  JR  2,2  LD"WJR"  -2.6  -2.1  0.6  35.7 
4  AZH  2,2  LD"AZH"  -8.5  0.2  -6.6  26.6 
5  WT 18  2,2  "tb24"  0.7  2.1  0.3  27.8 
6  CMcG  2,2  Dw2  31.8  NT  -5.6  43.4 
7  PAL  2,2  Dw2  59.9  43.2  6.6  35.6 
8  SHI  2,2  Dw2  37.0  42.3  -2.7  29.2 
9  BGE  2,2  Dwl2  37.8  44.0  1.8  37.8 
* T  cell clones were used at an effector/target ratio of 10:1. Autologous PBL (M 15) were stimulated with measles 
virus (MV) as described in Material and Methods and used at an effector/target ratio of 40:1. Values are expressed 
as means of triplicate cultures. 
DR2  targets that expressed HLA-D specificities Dw2 or Dwl2  (cell lines 6-9, 
Table I).  Both CL34  and E4-4 failed to lyse the HLA-DR2  HCL that express 
the HLA-D specificities LD WJR, LD AZH, or tb24 (targets 3-5, Table I). None 
of the DR2 HCL lines could be lysed by the DR4-restricted clone CL 14. 
The pattern of lysis by clones CL34 and E4-4 correlated precisely with the/3 
chain gel profiles of immunoprecipitated DR molecules from these DR2  HCL 
(Fig.  1). Gel patterns are those of/3 chains immunoprecipitated with monoclonal 
antibodies directed at products of the DR  locus from six  DR2  HCL.  /3 chain 
profiles from WJR, AZH, and WT18 (Fig.  1, left)  contain a series of spots that 
represent a  single polypeptide chain (gels made after neuraminidase treatment 
to  reduce electrophoretic heterogeneity associated  with  glycosylation [7  and 
below]). DR /3 chain profiles from cells CMcG, BGE, and SHI are also shown 
(Fig.  1, right).  In addition to a series of/3 chain spots similar to those in the other 
cell lines, each of these three HCL contain additional, more acidic/3 chain spots 
precipitated by this same antibody (Fig.  1,/32).  These consist of a series of spots 
of variable  intensity,  some  of which  overlap  the  more acidic  /31  spots.  The 
electrophoretic relationship between the/31 and/32 spots is clarified in the lower 
panel in Fig. 1. Separate immunoprecipitates from HCL, AZH, and CMcG were 
treated with neuraminidase, mixed, and coelectrophoresed. Neuraminidase treat- 
ment, as reported (7), reduces the electrophoretic complexity of the/31  and/32 
series of spots, and clearly separates them under nonequilibrium electrofocusing 
gel  conditions.  The  /31  spots  from  AZH  and  CMcG  overlap  in  the  mixed 
immunoprecipitates (Fig.  1, bottom),  whereas the/32 spots from CMcG appear as 
an additional acidic polypeptide. The/32  polypeptide is absent from cell lines 
WJR, AZH, and WT 18 (above, and reference 7), which correlates with the lack 
of killing of these cell lines by clones CL34 and E4-4 (Table I). 
To  verify this apparent  restriction to  the HLA-DR2  /32  molecule, we have 
identified an individual who is heterozygous HLA-DR2,4 (E3B, Table I) whose 
HLA-DR2-associated  D  specificity  was  typed  LD  tb24.  The  measles  virus- 
infected E3B line was efficiently lysed by clone CL14, which recognizes measles 
virus in the context of HLAoDR4. However, neither clones CL34 nor E4-4 could 
kill  this measles virus-infected B cell line, confirming the lack of the required 
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FIGURE  1.  Two-dimensional polyacrylamide gel electrophoresis patterns of immunoprecipi- 
tated 13 chains from DR2 homozygous cell lines. (upper panels) Separate immunoprecipitated 
/3 chains from DR2 homozygous cell lines (separate immunoprecipitates from six HLA-DR2- 
associated HCL, using monoclonal anti-DR framework antibodies). Each anode is aligned on 
the right;/3 chain region autoradiographs,  exposed for 7-10 d, are shown for comparison. 
Additional acidic polypeptide spots (/32) are present in the three panels on the right which are 
not present in the left panels. The relationship between the/31 and/32 polypeptides is clarified 
in the lower gel panel, in which a mixture of neuraminidase-treated immunoprecipitates from 
two HCL are shown. After neuraminidase digestion, the variable series of/31-associated spots 
resolves into two, more basic spots,  clearly distinct from the more acidic/52 polypeptide, as 
previously reported (7). 
Discussion 
It has been demonstrated  (6,  7) that at least three  Ia-like molecules, each of 
which may be a  product of a  separate  gene, are expressed on  HLA-DR HCL. 
There is considerable allelic variability for each of these molecules, even among 
cells expressing the same serologic HLA-DR specificities. It has been suggested 
(6, 7,  10) that this variability could account for the Ia structural polymorphisms 
fundamental  to HLA-controlled immune  responses and to HLA D/DR-associ- 
ated disease susceptibility. An important question, therefore, is to identify which 
Ia-like molecules have a  functional  role  in recognition  by antigen-specific,  im- 
munologically reactive cell populations. 
The  seven  HLA-DR2  HCL  used  in  this  study  represent  the  five  HLA-D 
clusters defined within HLA-DR2. In a previous study (7), two distinct/3 chains 
(DR/31  and  DR/32) were found on  HLA-DR2 HCL that  express the HLA-D- 
associated specificities Dw2 and Dwl2. The/31  polypeptide chain was invariant 
in all DR2 HCL tested, regardless of HLA-D type, while the/32 chain varied in 
a  manner  that  correlated  with  the  HLA-D  specificity.  HLA-DR2  HCL  that 
express HLA-D LD tb24, LD WJR, or LD AZH did not have an immunoprecip- 
itated  DR/32 chain  (Fig.  1).  The presence of the/32 chain  correlated precisely 
with  the  susceptibility  of measles  virus-infected  HLA-DR2  HCL  to  lysis  by 
measles virus-specific, OKT4  +, class II-restricted CTL clones (Table I). Measles 
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detected (cell lines AZH, WJR, and WT18) could not be lysed by these HLA 
class II-restricted CTL clones. 
In this study, the presence of a DR/32 polypeptide is inferred from immuno- 
precipitation with anti-DR monocional antibodies. The possibility exists that lines 
AZH, WJR,  WT18,  and E3B might indeed possess a  variant DR/32  molecule 
sufficiently different from "normal" Dw2 and  Dwl2  DR /32  molecules that it 
does not react with the anti-DR monoclonal antibodies.  If this is the case, our 
interpretation linking T  cell response to DR/32  is still valid, since such variant 
molecules have  apparently  also  lost  epitopes  governing  T  cell  responses.  In 
essence, such variants would be naturally occurring mutants that permit mapping 
of the restriction element to this chain. A more likely possibility, however, is that 
the Dw2- and Dwl2-typed DR2 HCL (and not the WJR, AZH, or tb24  HCL) 
contain a separate gene encoding DR/32 that can act as the restriction element 
for these measles virus-specific CTL clones. 
These  studies  demonstrate  that  delineation  of  HLA-DR2  into  various 
subgroups can have a functional significance that parallels the structural differ- 
ences within the HLA-D region. Therefore, restriction elements that potentially 
function as  disease-associated genetic markers may not correspond to  broad, 
serologically defined, public HLA specificities (HLA-DR serotypes) but rather 
with products of individual loci, as has been suggested for HLA class II molecules 
present in juvenile rheumatoid arthritis (11). 
It is of interest that both HLA-DR2 and Dw2 occur with increased frequency 
in patients with MS (12-14). This study links the DR/32 polypeptide present in 
the HLA-Dw2 haplotype (which is more prevalent in  MS patient populations) 
with the susceptibility of these cells to lysis by measles virus-specific, HLA class 
II-restricted CTL clones derived from a patient with MS. Measles virus has been 
considered as a possible etiological factor in the MS disease process (15, 16), and 
OKT4 +,  measles virus-specific CTL  could contribute to  development of MS 
plaque lesions (8,  17).  We do not yet know whether such a direct implication of 
specific restriction elements forms a mechanistic basis for the genetic associations 
with  disease susceptibility.  However,  the  identification of the  DR2-associated 
molecule that appears to be a preferential restriction element for measles virus- 
specific CTL could provide a valuable clue for molecular genetic investigations 
of an HLA-linked influence on susceptibility to MS. 
Summary 
By using a panel of HLA-D-defined subtypes of HLA-DR2 HCL with known 
/3 chain structural variabilities, we have demonstrated that HLA-DR2, OKT4 + 
cytotoxic T  lymphocyte (C1 L) clones specific for measles virus are apparently 
restricted  to  a  distinct  DR  /3  chain.  The  presence  of this  DR  /32  molecule 
correlated precisely with the susceptibility of measles virus-infected HLA-DR2 
HCL to lysis by these CTL clones. These studies demonstrate that delineation 
of HLA-DR2  into  various  subgroups  can  have a  functional significance that 
parallels the structural differences within the HLA-D region. These results are 
discussed in the context of the possible association of HLA class  II-restricted, 
measles virus-specific CTL and multiple sclerosis. 268  JACOBSON  ET  AL.  BRIEF  DEFINITIVE REPORT 
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